دورية أكاديمية

1092P Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease

التفاصيل البيبلوغرافية
العنوان: 1092P Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease
المؤلفون: Bharmal, M., Nolte, S., Lebbé, C., Mortier, L., Brohl, A.S., Fazio, N., Grob, J-J., Prinzi, N., Hanna, G.J., Hassel, J., Kiecker, F., Ellers-Lenz, B., Bajars, M., Guezel, G., Nghiem, P., Hunger, M., Schlichting, M., Henry-Szatkowski, M., D'Angelo, S.
المصدر: In Annals of Oncology September 2020 31 Supplement 4:S740-S741
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2020.08.1216